Effectiveness and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: A protocol for Systematic review and Meta-analysis

Type 1 Diabetes Mellitus (T1DM) has long required insulin treatment. Sotagliflflozin (SOTA), as a dual SGLT-1/2 inhibitor, has the potential to be the first oral antidiabetic drug (OAD) to be approved for T1DM in the US market. It is important to evaluate the effectiveness of SOTA for T1DM. Web of S...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medicine (Baltimore) 2019-08, Vol.98 (33), p.e16850-e16850
Hauptverfasser:	Chen, Mao-Bing, Xu, Rui-Jun, Zheng, Qi-Han, Zheng, Xu-Wen, Wang, Hua, Ding, Yun-Long, Yue, Mao-Xing
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Combined Modality Therapy Diabetes Mellitus, Type 1 - drug therapy Glycated Hemoglobin A - drug effects Glycosides - administration & dosage Humans Meta-Analysis as Topic Randomized Controlled Trials as Topic Sodium-Glucose Transporter 2 Inhibitors - administration & dosage Study Protocol Systematic Review Systematic Reviews as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!